Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
Clinical trial NCT06117371 · COMPLETED
Trial details
- NCT number
- NCT06117371
- Sponsor
- BeBetter Med Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2024-10-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.